Claraphi Advisory Network’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$3.34M Buy
9,136
+3,924
+75% +$1.39M 1.33% 18
2022
Q3
$1.69M Buy
5,212
+1,030
+25% +$326K 0.91% 22
2022
Q2
$1.36M Buy
+4,182
New +$1.26M 0.48% 47
2022
Q1
Sell
-766
Closed -$212K 318
2021
Q4
$212K Buy
+766
New +$194K 0.07% 267
2021
Q2
Sell
-1,134
Closed -$212K 331
2021
Q1
$212K Buy
+1,134
New +$222K 0.06% 284
2020
Q2
Sell
-159
Closed -$22K 796
2020
Q1
$22K Buy
+159
New +$21.8K 0.01% 616
2019
Q2
Sell
-1,853
Closed -$241K 259
2019
Q1
$241K Sell
1,853
-31
-2% -$3.77K 0.15% 175
2018
Q4
$218K Buy
+1,884
New +$210K 0.17% 171

Other funds holding LLY

Claraphi Advisory Network's LLY Position: Q4 2022 in Review

Claraphi Advisory Network increased its Eli Lilly (LLY) stake by 75% in Q4 2022, buying an estimated $1.39M and bringing the position to 9,136 shares worth $3.34M. The position accounts for 1.33% of the portfolio, ranked #18.

Claraphi Advisory Network first reported a position in LLY in Q4 2018 and has held it in 8 quarters since. 2,672 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Claraphi Advisory Network held 9,136 shares of Eli Lilly worth $3.34M as of Q4 2022.
  • Claraphi Advisory Network bought 3,924 Eli Lilly shares in Q4 2022, an estimated $1.39M.
  • Eli Lilly made up 1.33% of Claraphi Advisory Network's portfolio in Q4 2022, its #18 holding.
  • Claraphi Advisory Network first reported a position in Eli Lilly in Q4 2018 and has held it in 8 quarters since.
  • 2,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Claraphi Advisory Network's 13F filing for Q4 2022, filed 14 Feb 2023.